FDA to hold regulations hearing on cannabidoil, an ingredient in cannabis

Health

The FDA wants to know more about what the public thinks of products containing an ingredient in marijuana – CBD.

The agency is holding a public hearing next month on CBD products. CBD is short for cannabidoil, one of the ingredients in cannabis.

Related: Lamont still confident marijuana will become legal in Connecticut

It is marketed for everything from helping to relieve pain to reducing stress and anxiety, but the ingredient is not sanctioned by the FDA.

Federal officials want to discuss developing a regulatory framework for the use of CBD in products.

The public hearing is scheduled for May 31st.

Copyright 2019 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories

Don't Miss

More Don't Miss